Nachrichten zur DexCom Inc. Aktie

DXCM Inks Deal With Nanowear to Boost CGM Application Beyond Diabetes

DexComs recent licensing deal with Nanowear is likely to reinforce the broader potential of CGMs in continuous metabolic health monitoring.…

DXCM Stock Falls as FDA Warnings Raise Concern for 15-Day G7 Approval

DexCom receives a warning letter from the FDA citing several issues with its popular G6 & G7 sensor manufacturing. The…

Nasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does Next

Equity markets started 2025 pretty well, but things havent been so rosy in the past couple of months. The tech-heavy…

Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests

Novo Nordisks weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom…

Dexcom receives FDA warning letter for two U.S. manufacturing facilities By Reuters

Dexcom receives FDA warning letter for two U.S. manufacturing facilities…

Dexcom receives FDA warning letter for two U.S. manufacturing facilities

Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following inspections…

3 Growth Stocks to Buy and Hold Forever

The best way to grow your wealth and better prepare yourself for retirement is to accumulate shares of solid growth…

The Zacks Analyst Blog Highlights AbbVie, Amgen, Stryker, Dexcom and Medtronic

AbbVie, Amgen, Stryker, Dexcom and Medtronic are included in this Analyst Blog.…

DexCom (DXCM) Q4 2024 Earnings Call Transcript

DXCM earnings call for the period ending December 31, 2024.…

DexCom: Revenue Up, EPS Misses Mark

DexCom reported mixed earnings, with revenue surpassing estimates but earnings per share falling short.…

Heres What Key Metrics Tell Us About DexCom (DXCM) Q4 Earnings

The headline numbers for DexCom (DXCM) give insight into how the company performed in the quarter ended December 2024, but…

DexCom (DXCM) Misses Q4 Earnings Estimates

DexCom (DXCM) delivered earnings and revenue surprises of -10% and 0.05%, respectively, for the quarter ended December 2024. Do the…

Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.

Most companies dont survive for decades, much less pay regular dividends for that long. However, some rare corporations can pull…

DXCM Q4 Earnings to Reflect Market Expansion & Stelo Impact?

DexCom Q4 results are likely to reflect strong growth on the back of U.S. sales expansion, global gains and Stelo…

DexCom (DXCM) Q4 Earnings Preview: Whats in the Cards?

DexCom (DXCM) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…

Should You Buy DexCom Stock Before Feb. 13?

DexCom (NASDAQ: DXCM) is a healthcare company that makes continuous glucose monitoring (CGM) devices, which help people track glucose levels. However,…

Prediction: This Top Growth Stock Will Outperform the Market in the Next Decade

Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period. The diabetes-focused company disappointed investors…

Got $2,000? 2 Top Growth Stocks to Buy and Hold for Years

The bull market of the past year or more has reinvigorated investors interest across a range of industries, and the…

How to keep profiting from this health-care stock thats breaking out

Tony Zhang gives an update on his successful Dexcom trade.…

DXCMs Preliminary Results Show Strong Growth: How to Play the Stock?

DexCom stock shines with strong fourth quarter and full-year 2024 preliminary results, driven by innovation and global expansion. Explore if…

DexCom: Fairly Priced In 2025; Why Im Not Expecting A Share Price Comeback

…

2 Healthcare Stocks to Buy Hand Over Fist in January

Stocks tend to perform well in January, but thats not a good reason to invest this month. Strong returns arent…

Dexcom stock soars on upbeat 2025 revenue outlook By Investing.com

Dexcom stock soars on upbeat 2025 revenue outlook…

3 Beaten-Down Stocks That May Be Due for Big Comebacks in 2025

The past year was a great one for the stock market as a whole, but there were plenty of companies…

These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in 2024

Now that weve shut the door on 2024, its useful to look back at some of the best -- and,…

DexCom, Abbott Agree to Settlement in Patent Litigation

…

DexCom (DXCM) Soars 5.6%: Is Further Upside Left in the Stock?

DexCom (DXCM) saw its shares surge in the last session with trading volume being higher than average. The latest trend…

1 Reason to Sell DexCom Stock, and 1 Reason to Buy

Shares of the medical-device maker DexCom (NASDAQ: DXCM) are down by 37% this year. The diabetes-focused healthcare company disappointed investors…

2025 Picks: 2 Stocks to Buy Now for 50% Upside

Two S&P 500 stocks--DexCom and Albemarle--are already on sale for investors to buy in 2025.…

DXCM Stock Gains on the Launch of Proprietary Generative AI Platform

Dexcom announces the first Generative AI platform in glucose biosensing.…

Dexcoms over-the-counter glucose monitor now offers users an AI summary of how sleep, meals and more impact sugar levels

Dexcom is bringing generative AI to Stelo users, starting with weekly personalized reports about their glucose…

DexCom: Brighter 2025 From Stelo Ramp

…

Dexcom shares up as Diabetes Association updates guidelines By Investing.com

Dexcom shares up as Diabetes Association updates guidelines…

How to buy a health care turnaround story at a discount using options

Tony Zhang describes selling a cash secured put in Dexcom.…

United Kingdom Diabetes Device Market Forecast Report 2024-2032: Competitive Landscape, SWOT, Porters Five Forces, Reimbursement Policies, Key Segments

The major participants in the United Kingdom Diabetes Device market includes Abbott Laboratories, Roche, Medtronic, Novo Nordisk A/S, Terumo Corporation,…

DexCom, Orthofix, Spire Global, and Moderna Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information

SAN DIEGO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP investigates potential violations of federal and state…

3 Reasons to Buy DexCom Stock Like Theres No Tomorrow

Medical device specialist DexCom (NASDAQ: DXCM) is going through a rough patch. The companys shares are down sharply year to…

2 Excellent Healthcare Stocks to Hold Through the Next Decade

Although excellent medical care is always in high demand, the healthcare sector continuously evolves. Companies arent automatically worth investing in…

[Latest] Global Point of Care Glucose Testing Market Size/Share Worth USD 5,455.3 Million by 2033 at a 4.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…

dpa-AFX ProFeed